STERIS plc (STE)
USD 207.01
(-1.19%)
USD 207.01
(-1.19%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 836.11 Million USD | 211.77% |
| 2023 | 268.18 Million USD | -36.99% |
| 2022 | 425.61 Million USD | 31.65% |
| 2021 | 323.3 Million USD | -5.21% |
| 2020 | 341.08 Million USD | -17.1% |
| 2019 | 411.46 Million USD | 1.99% |
| 2018 | 403.45 Million USD | 77.27% |
| 2017 | 227.59 Million USD | 6.89% |
| 2016 | 212.92 Million USD | -6.29% |
| 2015 | 227.21 Million USD | 9.87% |
| 2014 | 206.8 Million USD | -14.83% |
| 2013 | 242.82 Million USD | 9.23% |
| 2012 | 222.31 Million USD | 160.9% |
| 2011 | 85.21 Million USD | -58.17% |
| 2010 | 203.71 Million USD | 16.11% |
| 2009 | 175.44 Million USD | 42.01% |
| 2008 | 123.54 Million USD | -10.28% |
| 2007 | 137.7 Million USD | 25.53% |
| 2006 | 109.69 Million USD | -24.34% |
| 2005 | 144.99 Million USD | 3.3% |
| 2004 | 140.35 Million USD | 11.6% |
| 2003 | 125.76 Million USD | 56.02% |
| 2002 | 80.61 Million USD | 233.47% |
| 2001 | 24.17 Million USD | -18.62% |
| 2000 | 29.7 Million USD | -78.22% |
| 1999 | 136.4 Million USD | 21.12% |
| 1998 | 112.61 Million USD | 33.43% |
| 1997 | 84.4 Million USD | 315.76% |
| 1996 | 20.3 Million USD | 54.96% |
| 1995 | 13.1 Million USD | 63.75% |
| 1994 | 8 Million USD | 247.83% |
| 1993 | 2.3 Million USD | 0.0% |
| 1992 | - USD | -100.0% |
| 1991 | 200 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 185.85 Million USD | -1.6% |
| 2024 FY | 905.41 Million USD | 237.61% |
| 2024 Q3 | 216.15 Million USD | 16.3% |
| 2024 Q4 | 246.37 Million USD | 13.98% |
| 2024 Q1 | 188.88 Million USD | -16.2% |
| 2023 FY | 268.18 Million USD | -36.99% |
| 2023 Q2 | -306.41 Million USD | -293.45% |
| 2023 Q1 | 158.39 Million USD | 72.43% |
| 2023 Q3 | 190.8 Million USD | 162.27% |
| 2023 Q4 | 225.4 Million USD | 18.13% |
| 2022 Q1 | 14.32 Million USD | -90.07% |
| 2022 FY | 425.61 Million USD | 31.65% |
| 2022 Q2 | 116.5 Million USD | 713.34% |
| 2022 Q3 | 202.93 Million USD | 74.19% |
| 2022 Q4 | 91.85 Million USD | -54.73% |
| 2021 FY | 323.3 Million USD | -5.21% |
| 2021 Q4 | 144.25 Million USD | -1.89% |
| 2021 Q1 | 114 Million USD | -27.74% |
| 2021 Q3 | 147.03 Million USD | 4.08% |
| 2021 Q2 | 141.26 Million USD | 23.91% |
| 2020 FY | 341.08 Million USD | -17.1% |
| 2020 Q2 | 126.73 Million USD | 15.12% |
| 2020 Q3 | 142.38 Million USD | 12.35% |
| 2020 Q4 | 157.76 Million USD | 10.8% |
| 2020 Q1 | 110.08 Million USD | -21.86% |
| 2019 Q4 | 140.87 Million USD | 102.46% |
| 2019 Q3 | 69.58 Million USD | -34.71% |
| 2019 Q2 | 106.57 Million USD | 12.87% |
| 2019 FY | 411.46 Million USD | 1.99% |
| 2019 Q1 | 94.42 Million USD | -16.9% |
| 2018 Q4 | 113.62 Million USD | 9.07% |
| 2018 FY | 403.45 Million USD | 77.27% |
| 2018 Q3 | 104.17 Million USD | 4.8% |
| 2018 Q2 | 99.4 Million USD | 15.24% |
| 2018 Q1 | 86.25 Million USD | 47.13% |
| 2017 Q3 | 25.88 Million USD | -62.79% |
| 2017 FY | 227.59 Million USD | 6.89% |
| 2017 Q1 | 73.52 Million USD | -25.98% |
| 2017 Q2 | 69.56 Million USD | -5.38% |
| 2017 Q4 | 58.62 Million USD | 126.5% |
| 2016 Q1 | 44.21 Million USD | -35.24% |
| 2016 Q2 | 22.66 Million USD | -48.74% |
| 2016 Q3 | 46.72 Million USD | 106.16% |
| 2016 Q4 | 99.32 Million USD | 112.59% |
| 2016 FY | 212.92 Million USD | -6.29% |
| 2015 FY | 227.21 Million USD | 9.87% |
| 2015 Q2 | 53.42 Million USD | 20.95% |
| 2015 Q1 | 44.16 Million USD | -25.9% |
| 2015 Q3 | 61.34 Million USD | 14.83% |
| 2015 Q4 | 68.27 Million USD | 11.29% |
| 2014 Q3 | 55.89 Million USD | 11.11% |
| 2014 Q4 | 59.6 Million USD | 6.65% |
| 2014 FY | 206.8 Million USD | -14.83% |
| 2014 Q1 | 41.01 Million USD | -37.01% |
| 2014 Q2 | 50.3 Million USD | 22.65% |
| 2013 Q3 | 67.14 Million USD | 7.81% |
| 2013 Q4 | 65.11 Million USD | -3.02% |
| 2013 FY | 242.82 Million USD | 9.23% |
| 2013 Q1 | 48.3 Million USD | -34.77% |
| 2013 Q2 | 62.27 Million USD | 28.93% |
| 2012 Q4 | 74.04 Million USD | 37.83% |
| 2012 Q1 | 46.9 Million USD | -18.4% |
| 2012 Q3 | 53.72 Million USD | 12.76% |
| 2012 FY | 222.31 Million USD | 160.9% |
| 2012 Q2 | 47.64 Million USD | 1.58% |
| 2011 Q4 | 57.47 Million USD | 60.4% |
| 2011 Q1 | -63 Million USD | -222.67% |
| 2011 Q2 | 54.9 Million USD | 187.15% |
| 2011 Q3 | 35.83 Million USD | -34.74% |
| 2011 FY | 85.21 Million USD | -58.17% |
| 2010 Q3 | 59.42 Million USD | 18.7% |
| 2010 FY | 203.71 Million USD | 16.11% |
| 2010 Q2 | 50.06 Million USD | 16.81% |
| 2010 Q4 | 51.35 Million USD | -13.58% |
| 2010 Q1 | 42.86 Million USD | -9.99% |
| 2009 FY | 175.44 Million USD | 42.01% |
| 2009 Q1 | 35.04 Million USD | -16.71% |
| 2009 Q4 | 47.61 Million USD | 3.93% |
| 2009 Q3 | 45.81 Million USD | -2.45% |
| 2009 Q2 | 46.96 Million USD | 34.04% |
| 2008 Q4 | 42.06 Million USD | 25.72% |
| 2008 FY | 123.54 Million USD | -10.28% |
| 2008 Q2 | 26.44 Million USD | 22.63% |
| 2008 Q1 | 21.56 Million USD | -58.41% |
| 2008 Q3 | 33.46 Million USD | 26.52% |
| 2007 Q2 | 92.22 Million USD | 262.23% |
| 2007 Q3 | 33.85 Million USD | -63.3% |
| 2007 Q4 | 51.85 Million USD | 53.18% |
| 2007 FY | 137.7 Million USD | 25.53% |
| 2007 Q1 | 25.46 Million USD | 36.87% |
| 2006 Q4 | 18.6 Million USD | -52.37% |
| 2006 Q2 | 27.04 Million USD | -0.74% |
| 2006 Q1 | 27.24 Million USD | -41.02% |
| 2006 Q3 | 39.05 Million USD | 44.4% |
| 2006 FY | 109.69 Million USD | -24.34% |
| 2005 Q2 | 30.86 Million USD | 10.18% |
| 2005 Q3 | 39.91 Million USD | 29.3% |
| 2005 FY | 144.99 Million USD | 3.3% |
| 2005 Q4 | 46.19 Million USD | 15.75% |
| 2005 Q1 | 28.01 Million USD | -36.3% |
| 2004 Q1 | 26.22 Million USD | -37.51% |
| 2004 Q3 | 37.82 Million USD | 17.02% |
| 2004 Q2 | 32.32 Million USD | 23.26% |
| 2004 Q4 | 43.98 Million USD | 16.27% |
| 2004 FY | 140.35 Million USD | 11.6% |
| 2003 Q2 | 29.18 Million USD | 41.7% |
| 2003 Q3 | 34.02 Million USD | 16.61% |
| 2003 FY | 125.76 Million USD | 56.02% |
| 2003 Q1 | 20.59 Million USD | -31.93% |
| 2003 Q4 | 41.96 Million USD | 23.32% |
| 2002 Q3 | 23.51 Million USD | 40.5% |
| 2002 Q1 | 10.11 Million USD | 154.17% |
| 2002 FY | 80.61 Million USD | 233.47% |
| 2002 Q4 | 30.25 Million USD | 28.67% |
| 2002 Q2 | 16.73 Million USD | 65.36% |
| 2001 Q2 | 15.93 Million USD | 184.32% |
| 2001 FY | 24.17 Million USD | -18.62% |
| 2001 Q4 | -18.67 Million USD | -187.66% |
| 2001 Q1 | 5.6 Million USD | 116.02% |
| 2001 Q3 | 21.3 Million USD | 33.68% |
| 2000 Q4 | -34.99 Million USD | -273.24% |
| 2000 FY | 29.7 Million USD | -78.22% |
| 2000 Q3 | 20.2 Million USD | -23.19% |
| 2000 Q2 | 26.3 Million USD | 45.3% |
| 2000 Q1 | 18.1 Million USD | -51.47% |
| 1999 Q4 | 37.3 Million USD | -7.9% |
| 1999 FY | 136.4 Million USD | 21.12% |
| 1999 Q1 | 25.75 Million USD | -27.0% |
| 1999 Q2 | 32.7 Million USD | 26.97% |
| 1999 Q3 | 40.5 Million USD | 23.85% |
| 1998 Q3 | 31.96 Million USD | 24.65% |
| 1998 FY | 112.61 Million USD | 33.43% |
| 1998 Q1 | 19.73 Million USD | -23.51% |
| 1998 Q2 | 25.64 Million USD | 29.92% |
| 1998 Q4 | 35.27 Million USD | 10.38% |
| 1997 Q3 | 21.9 Million USD | 10.61% |
| 1997 Q1 | 16.9 Million USD | 168.25% |
| 1997 FY | 84.4 Million USD | 315.76% |
| 1997 Q4 | 25.8 Million USD | 17.81% |
| 1997 Q2 | 19.8 Million USD | 17.16% |
| 1996 Q2 | 4.6 Million USD | 21.05% |
| 1996 FY | 20.3 Million USD | 54.96% |
| 1996 Q4 | 6.3 Million USD | 12.5% |
| 1996 Q3 | 5.6 Million USD | 21.74% |
| 1996 Q1 | 3.8 Million USD | -5.0% |
| 1995 Q2 | 3 Million USD | 15.38% |
| 1995 Q3 | 3.5 Million USD | 16.67% |
| 1995 Q4 | 4 Million USD | 14.29% |
| 1995 FY | 13.1 Million USD | 63.75% |
| 1995 Q1 | 2.6 Million USD | -3.7% |
| 1994 Q2 | 1.7 Million USD | 13.33% |
| 1994 Q4 | 2.7 Million USD | 28.57% |
| 1994 Q3 | 2.1 Million USD | 23.53% |
| 1994 Q1 | 1.5 Million USD | 25.0% |
| 1994 FY | 8 Million USD | 247.83% |
| 1993 Q1 | 200 Thousand USD | 102.44% |
| 1993 FY | 2.3 Million USD | 0.0% |
| 1993 Q2 | 300 Thousand USD | 50.0% |
| 1993 Q3 | 700 Thousand USD | 133.33% |
| 1993 Q4 | 1.2 Million USD | 71.43% |
| 1992 Q2 | 2.5 Million USD | -26.47% |
| 1992 Q4 | -8.2 Million USD | -341.18% |
| 1992 FY | - USD | -100.0% |
| 1992 Q1 | 3.4 Million USD | 153.13% |
| 1992 Q3 | 3.4 Million USD | 36.0% |
| 1991 FY | 200 Thousand USD | 0.0% |
| 1991 Q3 | 2.5 Million USD | 4.17% |
| 1991 Q1 | 2.5 Million USD | 0.0% |
| 1991 Q2 | 2.4 Million USD | -4.0% |
| 1991 Q4 | -6.4 Million USD | -356.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Abbott Laboratories | 6.47 Billion USD | 87.093% |
| Allurion Technologies Inc. | -78.07 Million USD | 1170.875% |
| Artivion, Inc. | 5.74 Million USD | -14461.442% |
| Avanos Medical, Inc. | 4.2 Million USD | -19807.571% |
| Butterfly Network, Inc. | -145.61 Million USD | 674.217% |
| Butterfly Network, Inc. | -145.61 Million USD | 674.217% |
| Bio-Rad Laboratories, Inc. | 383.79 Million USD | -117.855% |
| Boston Scientific Corporation | 2.34 Billion USD | 64.314% |
| Perspective Therapeutics, Inc. | -15.18 Million USD | 5607.298% |
| CONMED Corporation | 130.78 Million USD | -539.302% |
| Edwards Lifesciences Corporation | 1.53 Billion USD | 45.498% |
| Paragon 28, Inc. | -37.3 Million USD | 2341.062% |
| Glaukos Corporation | -128.7 Million USD | 749.664% |
| Globus Medical, Inc. | 133.14 Million USD | -527.99% |
| Inspire Medical Systems, Inc. | -40.27 Million USD | 2176.229% |
| Integer Holdings Corporation | 167.33 Million USD | -399.682% |
| Medtronic plc | 5.14 Billion USD | 83.746% |
| Nevro Corp. | -99.3 Million USD | 941.944% |
| Owlet, Inc. | -28.63 Million USD | 3020.222% |
| Penumbra, Inc. | 73.55 Million USD | -1036.787% |
| Vicarious Surgical Inc. | -80.66 Million USD | 1136.518% |
| Smith & Nephew plc | 425 Million USD | -96.734% |
| Sonendo, Inc. | -57.74 Million USD | 1547.999% |
| Stryker Corporation | 3.88 Billion USD | 78.495% |
| Vapotherm, Inc. | -39.08 Million USD | 2239.504% |
| Zimmer Biomet Holdings, Inc. | 1.27 Billion USD | 34.561% |